Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02875067
Title Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors New York University School of Medicine
Indications

Hodgkin's lymphoma

non-Hodgkin lymphoma

Therapies

Lenalidomide + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.